IONS
IONS
NASDAQ · Biotechnology

Ionis Pharmaceuticals Inc

$69.68
-1.11 (-1.57%)
As of Mar 24, 9:42 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 22 76%
Hold 7 24%
Sell 0 0%
Price Target
Analyst Price Target +7.5% upside
Low Target $58.43
Average Target $74.94
High Target $113.95
Current Price $69.68
Current
$69.68
Target
$74.94
$58.43 $74.94 avg $113.95
Scenario Analysis
Bear Case
$58.43
-16.1%
Low target
Base Case
$74.94
+7.5%
Avg target
Bull Case
$113.95
+63.5%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$86.74
-19.7% from high
52-Week Low
$23.95
+190.9% from low
50-Day SMA
$80.92
-13.9% vs SMA
200-Day SMA
$60.03
+16.1% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$74.94
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%